Paper23567973
Gas6 induces cancer cell migration and epithelial-mesenchymal transition through upregulation of MAPK and Slug.
Lee Y and 2 others. Biochem Biophys Res Commun, 2013. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. Gas6 induces cancer cell migration and epithelial-mesenchymal transition through upregulation of MAPK and Slug. Papers, record 23567973. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23567973
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gas6 induces cancer cell migration and epithelial-mesenchymal transition through upregulation of MAPK and Slug.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epithelial-Mesenchymal Transition | Major topic |
| Intercellular Signaling Peptides and Proteins | Major topic |
| MAP Kinase Signaling System | Major topic |
| Neoplasm Invasiveness | Major topic |
| Transcription Factors | Major topic |
| Up-Regulation | Major topic |
| Activating Transcription Factor 2 | |
| Cell Line, Tumor | |
| Cell Movement | |
| Down-Regulation | |
| HEK293 Cells | |
| Humans | |
| JNK Mitogen-Activated Protein Kinases | |
| Male | |
| Phosphorylation | |
| Snail Family Transcription Factors | |
| Growth Arrest-Specific Protein 6 |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41789109 | The myeloid SRC family kinase HCK regulates breast cancer growth by activating tumor-associated macrophage-led invasion and inhibiting cytotoxic T cell activity. | Front Immunol | 2026 | https://conductscience.org/library/papers/41789109 | PubMed |
| 41253273 | Impacts of trichothecene mycotoxins on human colonic epithelial cells: molecular mechanisms and signaling pathways. | J Adv Res | 2026 | https://conductscience.org/library/papers/41253273 | PubMed |
| 40705153 | Characterization of extracellular vesicles derived from cortical bone stem cells compared with mesenchymal stem cells. | Mol Cell Biochem | 2025 | https://conductscience.org/library/papers/40705153 | PubMed |
| 39451556 | Knockdown of Gas6 Exerts Anti-Esophageal Cancer Effects by Inhibiting the PI3K/AKT Pathway. | Curr Issues Mol Biol | 2024 | https://conductscience.org/library/papers/39451556 | PubMed |
| 37348477 | Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell Carcinoma. | Urol Int | 2023 | https://conductscience.org/library/papers/37348477 | PubMed |
| 37265798 | Gas6/AXL pathway: immunological landscape and therapeutic potential. | Front Oncol | 2023 | https://conductscience.org/library/papers/37265798 | PubMed |
| 36989239 | Axl contributes to efficient migration and invasion of melanoma cells. | PLoS One | 2023 | https://conductscience.org/library/papers/36989239 | PubMed |
| 36028390 | New insights into vitamin K biology with relevance to cancer. | Trends Mol Med | 2022 | https://conductscience.org/library/papers/36028390 | PubMed |
| 35760058 | Growth Arrest-Specific 6 in Chromophobe Renal Cell Carcinoma. | Oncology | 2022 | https://conductscience.org/library/papers/35760058 | PubMed |
| 35636929 | Mertk: An emerging target in cancer biology and immuno-oncology. | Int Rev Cell Mol Biol | 2022 | https://conductscience.org/library/papers/35636929 | PubMed |
| 34809669 | TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34809669 | PubMed |
| 33105713 | The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer. | Cells | 2020 | https://conductscience.org/library/papers/33105713 | PubMed |
| 33028808 | Emerging role of tumor cell plasticity in modifying therapeutic response. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/33028808 | PubMed |
| 32754286 | DNA methylation maintains the CLDN1-EPHB6-SLUG axis to enhance chemotherapeutic efficacy and inhibit lung cancer progression. | Theranostics | 2020 | https://conductscience.org/library/papers/32754286 | PubMed |
| 32547108 | Overexpression of GAS6 Promotes Cell Proliferation and Invasion in Bladder Cancer by Activation of the PI3K/AKT Pathway. | Onco Targets Ther | 2020 | https://conductscience.org/library/papers/32547108 | PubMed |
| 32503267 | Small Ones to Fight a Big Problem-Intervention of Cancer Metastasis by Small Molecules. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32503267 | PubMed |
| 32483414 | Skipping of exon 10 in Axl pre-mRNA regulated by PTBP1 mediates invasion and metastasis process of liver cancer cells. | Theranostics | 2020 | https://conductscience.org/library/papers/32483414 | PubMed |
| 32432570 | Qigesan inhibits esophageal cancer cell invasion and migration by inhibiting Gas6/Axl-induced epithelial-mesenchymal transition. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/32432570 | PubMed |
| 31960736 | Reverse Cardio-Oncology: Cancer Development in Patients With Cardiovascular Disease. | J Am Heart Assoc | 2020 | https://conductscience.org/library/papers/31960736 | PubMed |
| 31028135 | ssExpression level of GAS6-mRNA influences the prognosis of acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation. | Biosci Rep | 2019 | https://conductscience.org/library/papers/31028135 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ATF2 | 1386 | PubTator's text mining | https://conductscience.org/library/genes/1386 | NCBI Gene |
| AXL | 558 | PubTator's text mining | https://conductscience.org/library/genes/558 | NCBI Gene |
| CDH1 | 999 | PubTator's text mining | https://conductscience.org/library/genes/999 | NCBI Gene |
| GAS6 | 2621 | PubTator's text mining | https://conductscience.org/library/genes/2621 | NCBI Gene |
| JUN | 3725 | PubTator's text mining | https://conductscience.org/library/genes/3725 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| MAPK3 | 5595 | PubTator's text mining | https://conductscience.org/library/genes/5595 | NCBI Gene |
| MAPK8 | 5599 | PubTator's text mining | https://conductscience.org/library/genes/5599 | NCBI Gene |
| SNAI1 | 6615 | PubTator's text mining | https://conductscience.org/library/genes/6615 | NCBI Gene |
| SNAI2 | 6591 | PubTator's text mining | https://conductscience.org/library/genes/6591 | NCBI Gene |
| VIM | 7431 | PubTator's text mining | https://conductscience.org/library/genes/7431 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23567973
GET https://conductscience.org/api/papers/v1/23567973/cited_by?page=2